Utility of the Enhanced Liver Fibrosis score as a blood biomarker of pulmonary fibrosis secondary to SARS-CoV-2 pneumonia
- 24 August 2023
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 218, 107394
Abstract
No abstract availableKeywords
Funding Information
- Instituto de Salud Carlos III (PI21/01046)
- European Regional Development Fund
This publication has 31 references indexed in Scilit:
- Non‐invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis BAlimentary Pharmacology & Therapeutics, 2013
- The Enhanced Liver Fibrosis (ELF) score: Normal values, influence factors and proposed cut-off valuesJournal of Hepatology, 2013
- Clinical significance of serum hyaluronan in chronic fibrotic interstitial pneumoniaRespirology, 2013
- Role of hyaluronan and hyaluronan-binding proteins in lung pathobiologyAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Fleischner Society: Glossary of Terms for Thoracic ImagingRadiology, 2008
- Fibroblasts Isolated from Normal Lungs and Those with Idiopathic Pulmonary Fibrosis Differ in Interleukin-6/gp130-Mediated Cell Signaling and ProliferationThe American Journal of Pathology, 2003
- Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosisJournal of Clinical Investigation, 2001
- Tissue Inhibitor of Metalloproteinase 1 (TIMP-1) May Be an Autocrine Growth Factor in Scleroderma Fibroblasts.Journal of Investigative Dermatology, 1997
- Serum Levels of Aminoterminal Type III Procollagen Peptide and Hyaluronan Predict Mortality in Systemic SclerosisScandinavian Journal of Rheumatology, 1992
- Polymyositis and DermatomyositisNew England Journal of Medicine, 1975